The price of baricitinib is affected by factors such as dosage, region, and medical insurance policies. In China, the price per box typically ranges from 500 to 1500 RMB. The specific cost depends on the dosage (e.g., 2mg or 4mg) and the purchase channel. In some regions, inclusion in medical insurance reduces the out-of-pocket expense. It is recommended to obtain accurate information from hospitals or reputable pharmacies.
Main Factors Affecting Price
Drug Dosage
Baricitinib is commonly available in 2mg/tablet and 4mg/tablet strengths, with each box usually containing 28 tablets. The 4mg strength is generally more expensive than the 2mg strength; the dosage should be chosen based on the patient's condition and doctor's advice.
Regional and Medical Insurance Policies
This drug is included in the medical insurance catalogs of some provinces and cities. After medical insurance reimbursement, the out-of-pocket expense may be reduced by 30%-70%. In regions not covered by medical insurance or when purchased out-of-pocket, the cost may be higher.
Purchase Channels
Prices may vary between hospital pharmacies, offline pharmacies, and online platforms. It is recommended to purchase through legitimate channels to avoid the risk of counterfeit products.
Precautions for Medication Use
Baricitinib is a prescription drug and should be used strictly as directed by your doctor. It is primarily used to treat autoimmune diseases such as rheumatoid arthritis. Before use, a doctor must assess the indications, contraindications, and individual health status.
Contraindications and Side Effects: Baricitinib is contraindicated in individuals with active infections, abnormal liver function, or allergies. Common side effects include upper respiratory tract infections and elevated blood lipids. Regular monitoring of blood counts, liver and kidney function is necessary during treatment.
Avoid Self-Adjusting Dosage: Arbitrarily increasing or decreasing the dosage may affect efficacy or increase the risk of adverse reactions. The treatment plan should be adjusted by your doctor based on follow-up examination results.
If long-term use is required, it is recommended to choose a medication purchase channel that aligns with medical insurance policies and to have regular follow-up examinations to assess disease progression. If severe reactions such as fever or difficulty breathing occur, discontinue use immediately and seek medical attention.
